119 related articles for article (PubMed ID: 22030335)
1. Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.
Mayeur-Rousse C; Sorel N; Voldoire M; Canioni D; Brizard F; Randriamalala E; Turhan AG; Chomel JC
Leuk Res; 2012 Mar; 36(3):377-81. PubMed ID: 22030335
[No Abstract] [Full Text] [Related]
2. Submicroscopic deletion of FGFR1 gene is recurrently detected in myeloid and lymphoid neoplasms associated with ZMYM2-FGFR1 rearrangements: a case study.
Yang JJ; Park TS; Choi JR; Park SJ; Cho SY; Jun KR; Kim HR; Lee JN; Oh SH; Lee S; Kim B; Marschalek R; Meyer C
Acta Haematol; 2012; 127(2):119-23. PubMed ID: 22236811
[No Abstract] [Full Text] [Related]
3. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
Duckworth CB; Zhang L; Li S
Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
[TBL] [Abstract][Full Text] [Related]
4. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
[TBL] [Abstract][Full Text] [Related]
5. FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report.
Chang K; Liu JH; Yu SC; Lin CW
Hum Pathol; 2018 Apr; 74():114-121. PubMed ID: 29107667
[TBL] [Abstract][Full Text] [Related]
6. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.
Shaaban H; Dabu J; Al-Rabi K; Gauchan D; Guron G
Ann Hematol; 2013 Jan; 92(2):285-6. PubMed ID: 22941307
[No Abstract] [Full Text] [Related]
7. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
Kumar KR; Chen W; Koduru PR; Luu HS
Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
[TBL] [Abstract][Full Text] [Related]
8. Systemic mastocytosis associated with acute myeloid leukaemia.
Fong C; Tong M
Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
[No Abstract] [Full Text] [Related]
9. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
[TBL] [Abstract][Full Text] [Related]
10. A case of biphenotypic blast crisis of unclassified myeloproliferative disorder.
Kim J; Park CJ; Seo EJ; Lee JH; Yoo SJ; Choi SJ; Chi HS
Ann Hematol; 2002 Oct; 81(10):603-4. PubMed ID: 12424544
[TBL] [Abstract][Full Text] [Related]
11. [Low-dose combination cytarabine and etoposide for myeloid crisis transformed from unclassified chronic myeloproliferative disorder].
Matano S; Nakamura S; Kobayashi K; Kaya H; Yoshida T; Sugimoto T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1055-8. PubMed ID: 8687221
[TBL] [Abstract][Full Text] [Related]
12. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
[No Abstract] [Full Text] [Related]
13. High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis.
Barone S; Baer MR; Sait SN; Lawrence D; Block AW; Wetzler M
Am J Hematol; 2001 Jun; 67(2):119-24. PubMed ID: 11343384
[TBL] [Abstract][Full Text] [Related]
14. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
Fan XS; Wang SA
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
[No Abstract] [Full Text] [Related]
15. Imatinib mesylate responsiveness in aggressive systemic mastocytosis: novel association with a platelet derived growth factor receptor beta mutation.
Dalal BI; Horsman DE; Bruyèrè H; Forrest DL
Am J Hematol; 2007 Jan; 82(1):77-9. PubMed ID: 17133421
[No Abstract] [Full Text] [Related]
16. Acceleration of leukaemia with granulocyte colony-stimulating factor in a patient with aleukaemic leukaemia.
Fata F; Myers P; Addeo J; Nawabi I
Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):111-2. PubMed ID: 9349378
[No Abstract] [Full Text] [Related]
17. A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.
Buijs A; van Wijnen M; van den Blink D; van Gijn M; Klein SK
Cancer Genet; 2013 Apr; 206(4):140-4. PubMed ID: 23751892
[TBL] [Abstract][Full Text] [Related]
18. Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML.
Guerrasio A; Martinelli G; Ambrosetti A; Falda M; Paolino F; Rege-Cambrin G; Rosso C; Pignatti PF; Gasparini P; Perona G
Haematologica; 1991; 76(2):126-30. PubMed ID: 1937170
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.
Hennessy B; Giles F; Cortes J; O'brien S; Ferrajoli A; Ossa G; Garcia-Manero G; Faderl S; Kantarjian H; Verstovsek S
Am J Hematol; 2004 Nov; 77(3):209-14. PubMed ID: 15495258
[TBL] [Abstract][Full Text] [Related]
20. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
